ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial.

Michael C Kreissl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.